Cargando…

The potential of multi-compound nanoparticles to bypass drug resistance in cancer

PURPOSE: The therapeutic efficacy of conventional chemotherapy against several solid tumors is generally limited and this is often due to the development of resistance or poor delivery of the drugs to the tumor. Mechanisms of resistance may vary between cancer types. However, with current developmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Da Silva, C. G., Peters, Godefridus J., Ossendorp, Ferry, Cruz, Luis J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676819/ https://www.ncbi.nlm.nih.gov/pubmed/28887666 http://dx.doi.org/10.1007/s00280-017-3427-1

Ejemplares similares

Liposome-Based Drug Delivery Systems in Cancer Immunotherapy
por: Gu, Zili, et al.
Publicado: (2020)

Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance
por: de Klerk, Daniel J., et al.
Publicado: (2018)

Combining Photodynamic Therapy with Immunostimulatory Nanoparticles Elicits Effective Anti-Tumor Immune Responses in Preclinical Murine Models
por: Huis in ‘t Veld, Ruben Victor, et al.
Publicado: (2021)

Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma
por: Vahabi, Mahrou, et al.
Publicado: (2023)

Cationic Nanoparticle-Based Cancer Vaccines
por: Heuts, Jeroen, et al.
Publicado: (2021)

Effective chemoimmunotherapy by co-delivery of doxorubicin and immune adjuvants in biodegradable nanoparticles
por: Da Silva, Candido G., et al.
Publicado: (2019)

Bacterial Cellulose as Drug Delivery System for Optimizing Release of Immune Checkpoint Blocking Antibodies
por: Chung, Chih Kit, et al.
Publicado: (2022)

Protective autophagy by thymidine causes resistance to rapamycin in colorectal cancer cells in vitro
por: Bijnsdorp, I.V., et al.
Publicado: (2021)

Upconversion nanoparticle platform for efficient dendritic cell antigen delivery and simultaneous tracking
por: Yu, Zhenfeng, et al.
Publicado: (2022)

Current Challenges and Opportunities of Photodynamic Therapy against Cancer
por: Huis in ‘t Veld, Ruben V., et al.
Publicado: (2023)

Pharmacologically directed strategies in academic anticancer drug discovery based on the European NCI compounds initiative
por: Hendriks, Hans R, et al.
Publicado: (2017)

Drug Resistance Reversal Potential of Nanoparticles/Nanocomposites via Antibiotic’s Potentiation in Multi Drug Resistant P. aeruginosa
por: Pandey, Pratima, et al.
Publicado: (2021)

Statins markedly potentiate aminopeptidase inhibitor activity against (drug-resistant) human acute myeloid leukemia cells
por: Jansen, Gerrit, et al.
Publicado: (2023)

M1-derived extracellular vesicles enhance photodynamic therapy and promote immunological memory in preclinical models of colon cancer
por: Huis in ‘t Veld, Ruben V., et al.
Publicado: (2022)

Zinc-Phthalocyanine-Loaded Extracellular Vesicles Increase Efficacy and Selectivity of Photodynamic Therapy in Co-Culture and Preclinical Models of Colon Cancer
por: Lara, Pablo, et al.
Publicado: (2021)

Combinatorial Therapeutic Approaches with Nanomaterial-Based Photodynamic Cancer Therapy
por: Hao, Yang, et al.
Publicado: (2022)

USP1 deubiquitinase: cellular functions, regulatory mechanisms and emerging potential as target in cancer therapy
por: García-Santisteban, Iraia, et al.
Publicado: (2013)

Study of Combinatorial Drug Synergy of Novel Acridone Derivatives With Temozolomide Using in-silico and in-vitro Methods in the Treatment of Drug-Resistant Glioma
por: Chakravarty, Malobika, et al.
Publicado: (2021)

Role of Akt signaling in resistance to DNA-targeted therapy
por: Avan, Abolfazl, et al.
Publicado: (2016)

Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy [Image: see text]
por: Borst, Jannie, et al.
Publicado: (2021)

Local immunomodulation for cancer therapy: Providing treatment where needed
por: Fransen, Marieke F, et al.
Publicado: (2013)

Evaluating the potential of polymer nanoparticles for oral delivery of paclitaxel in drug-resistant cancer
por: Bhardwaj, V., et al.
Publicado: (2010)

PD-L1 immune suppression in cancer: Tumor cells or host cells?
por: Kleinovink, Jan Willem, et al.
Publicado: (2017)

Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines
por: Noordhuis, Paul, et al.
Publicado: (2019)

Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer
por: Abdullah, Ammara, et al.
Publicado: (2020)

Pancreatic cancer resistance conferred by stellate cells: looking for new preclinical models
por: Che, Pei Pei, et al.
Publicado: (2020)

Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the Spotlights
por: Fransen, Marieke F., et al.
Publicado: (2021)

Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis
por: Stelitano, Giovanni, et al.
Publicado: (2020)

Approaches to Improve Chemically Defined Synthetic Peptide Vaccines
por: Hos, Brett J., et al.
Publicado: (2018)

Correction: Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer
por: Abdullah, Ammara, et al.
Publicado: (2023)

A Dual-Color Bioluminescence Reporter Mouse for Simultaneous in vivo Imaging of T Cell Localization and Function
por: Kleinovink, Jan Willem, et al.
Publicado: (2019)

Doxorubicin Loaded Poloxamer Thermosensitive Hydrogels: Chemical, Pharmacological and Biological Evaluation
por: Chung, Chih Kit, et al.
Publicado: (2020)

Glutamate and α-ketoglutarate: key players in glioma metabolism
por: Maus, Andreas, et al.
Publicado: (2016)

Immune checkpoint inhibition combined with targeted therapy using a novel virus-like drug conjugate induces complete responses in a murine model of local and distant tumors
por: Huis in ‘t Veld, Ruben V., et al.
Publicado: (2023)

Jadomycins: A potential chemotherapy for multi‐drug resistant metastatic breast cancer
por: Bonitto, Esther P., et al.
Publicado: (2021)

Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis
por: Alghamdi, Saad, et al.
Publicado: (2020)

CD4 T Cells and Their Role in Antitumor Immune Responses
por: Toes, René E.M., et al.
Publicado: (1999)

Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors
por: Ossendorp, Ferry, et al.
Publicado: (1998)

Combinatorial therapeutic approaches of photodynamic therapy and immune checkpoint blockade for colon cancer treatment
por: Hao, Yang, et al.
Publicado: (2022)

In Vitro Testing of the Virus-Like Drug Conjugate Belzupacap Sarotalocan (AU-011) on Uveal Melanoma Suggests BAP1-Related Immunostimulatory Capacity
por: Ma, Sen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j7jbrfuo5kc85j57rl0mjnkc11